Impact of Open Source Software on Clinical Trials Grows With Release of OpenClinica 3.0 Electronic Data Capture...(nt with industry and government regulati...)

Date:10/14/2009

nt with industry and government regulations and guidelines such as 21 CFR Part 11, GCP, and HIPAA. OpenClinica is professionally supported by Akaza Research and has a worldwide open source community of over 7,500 users and developers. OpenClinica is freely available for download and use from http://www.openclinica.org.

About Akaza Research®

Akaza Research provides professional open source software for clinical trials. The company's flagship product, OpenClinica, provides electronic data capture (EDC) and clinical data management (CDM) capabilities for clinical research. By bringing open source software into the mainstream of clinical research, Akaza is able to provide a cost effective technology solution that is more flexible and transparent than proprietary, closed systems. Akaza Research provides a full spectrum of OpenClinica-related products and services to a worldwide customer base through its OpenClinica EnterpriseTM solution. For more information about Akaza Research, see http://www.akazaresearch.com.

###

Read the full story at http://www.prweb.com/releases/clinical_trials_software/electronic_data_capture/prweb3041334.htm.

'/>"/>

Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved

1 GOOD

Page: 1 2 3
Related biology technology :

1. New Survey Shows Devastating Impact of Rheumatoid Arthritis Pain on Intimate Relations
2. Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor
3. Plastics that convert light to electricity could have a big impact
4. Novel method predicts impact of a covert anthrax release
5. Novel method predicts impact of a covert anthrax release
6. OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427
7. World Micromachine Summit highlights technologies impacting energy and the environment
8. Event Alert: SPL R4 Compliance and its Impact on Regulatory Submission Processes
9. What Will Be the Impact of Programs of Study?
10. PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
11. Latest BioTrends Research Reports to Assess the Impact of the Withdrawal of Raptiva (efalizumab) on the Psoriasis Market